OBJECTIVES: Data on how to identify cancer survivors (css) at the greatest risk for cardiovascular conditions are limited. We aimed to characterize the clinical factors associated with ischemic heart disease (ihd) and congestive heart failure (chf) in css and to develop a stratification schema for predicting the risk of cardiovascular comorbidities in css. METHODS: Cancer survivors and non-cancer controls (nccs) were identified from the U.S. National Health and Nutrition Examination Survey. Independent factors associated with increased relative risk (rr) for cardiovascular conditions were determined. A risk stratification schema was devised that correlated risk score with the prevalence of cardiovascular comorbidities in cs. RESULTS: Baseline characteristics were similar for the 1869 css and 24,337 nccs included in the study. Compared with nccs, css were more likely to report ihd (13.7% vs. 5.2%), chf (7.9% vs. 2.1%), or both (4.2% vs. 1.2%; all p < 0.01). Based on multivariate analyses, risk factors for cardiovascular problems included ages 40-60 years (rr: 3.66; 95% ci: 1.87 to 7.17), 60-80 years (rr: 14.18; 95% ci: 7.65 to 26.30), and 80 years or older (rr: 25.34; 95% ci: 13.16 to 48.78); male sex (rr: 2.25; 95% ci: 1.72 to 2.94); U.S. citizenship (rr: 2.10; 95% ci: 1.08 to 4.08); annual incomes of $20,000-$45,000 (rr: 1.81; 95% ci: 1.21 to 2.70) and less than $20,000 (rr: 3.05; 95% ci: 1.81 to 5.14); comorbid diabetes mellitus (rr: 2.97; 95% ci: 2.05 to 4.32); and physical inactivity (rr: 1.98; 95% ci: 1.41 to 2.79). CONCLUSIONS: Independent risk factors for ihd and chf in css were identified. The risk stratification schema presented here may be helpful in developing a risk-based approach to preventive cardiovascular strategies for css.
OBJECTIVES: Data on how to identify cancer survivors (css) at the greatest risk for cardiovascular conditions are limited. We aimed to characterize the clinical factors associated with ischemic heart disease (ihd) and congestive heart failure (chf) in css and to develop a stratification schema for predicting the risk of cardiovascular comorbidities in css. METHODS:Cancer survivors and non-cancer controls (nccs) were identified from the U.S. National Health and Nutrition Examination Survey. Independent factors associated with increased relative risk (rr) for cardiovascular conditions were determined. A risk stratification schema was devised that correlated risk score with the prevalence of cardiovascular comorbidities in cs. RESULTS: Baseline characteristics were similar for the 1869 css and 24,337 nccs included in the study. Compared with nccs, css were more likely to report ihd (13.7% vs. 5.2%), chf (7.9% vs. 2.1%), or both (4.2% vs. 1.2%; all p < 0.01). Based on multivariate analyses, risk factors for cardiovascular problems included ages 40-60 years (rr: 3.66; 95% ci: 1.87 to 7.17), 60-80 years (rr: 14.18; 95% ci: 7.65 to 26.30), and 80 years or older (rr: 25.34; 95% ci: 13.16 to 48.78); male sex (rr: 2.25; 95% ci: 1.72 to 2.94); U.S. citizenship (rr: 2.10; 95% ci: 1.08 to 4.08); annual incomes of $20,000-$45,000 (rr: 1.81; 95% ci: 1.21 to 2.70) and less than $20,000 (rr: 3.05; 95% ci: 1.81 to 5.14); comorbid diabetes mellitus (rr: 2.97; 95% ci: 2.05 to 4.32); and physical inactivity (rr: 1.98; 95% ci: 1.41 to 2.79). CONCLUSIONS: Independent risk factors for ihd and chf in css were identified. The risk stratification schema presented here may be helpful in developing a risk-based approach to preventive cardiovascular strategies for css.
Authors: Thomas A Pearson; Steven N Blair; Stephen R Daniels; Robert H Eckel; Joan M Fair; Stephen P Fortmann; Barry A Franklin; Larry B Goldstein; Philip Greenland; Scott M Grundy; Yuling Hong; Nancy Houston Miller; Ronald M Lauer; Ira S Ockene; Ralph L Sacco; James F Sallis; Sidney C Smith; Neil J Stone; Kathryn A Taubert Journal: Circulation Date: 2002-07-16 Impact factor: 29.690
Authors: M L G Janssen-Heijnen; V E P P Lemmens; B E E M van den Borne; B Biesma; S B Oei; J W W Coebergh Journal: Crit Rev Oncol Hematol Date: 2007-01-02 Impact factor: 6.312
Authors: W J Louwman; M L G Janssen-Heijnen; S Houterman; A C Voogd; M J C van der Sangen; G A P Nieuwenhuijzen; J W W Coebergh Journal: Eur J Cancer Date: 2005-03 Impact factor: 9.162
Authors: Donald M Lloyd-Jones; Peter W F Wilson; Martin G Larson; Alexa Beiser; Eric P Leip; Ralph B D'Agostino; Daniel Levy Journal: Am J Cardiol Date: 2004-07-01 Impact factor: 2.778
Authors: Maciej Banach; Piotr Jankowski; Jacek Jóźwiak; Barbara Cybulska; Adam Windak; Tomasz Guzik; Artur Mamcarz; Marlena Broncel; Tomasz Tomasik; Jacek Rysz; Agnieszka Jankowska-Zduńczyk; Piotr Hoffman; Agnieszka Mastalerz-Migas Journal: Arch Med Sci Date: 2016-12-19 Impact factor: 3.318
Authors: Kerryn W Reding; Aaron K Aragaki; Richard K Cheng; Ana Barac; Sylvia Wassertheil-Smoller; Jessica Chubak; Marian C Limacher; W Gregory Hundley; Ralph D'Agostino; Mara Z Vitolins; Theodore M Brasky; Laurel A Habel; Eric J Chow; Rebecca D Jackson; Chu Chen; April Morgenroth; Wendy E Barrington; Matthew Banegas; Matthew Barnhart; Rowan T Chlebowski Journal: Oncologist Date: 2020-04-06
Authors: Joseph C Kong; Oliver Peacock; Peadar S Waters; Tim Eglinton; Satish K Warrier; Christopher Wakeman; Frank A Frizelle; Alexander G Heriot; Jacob J McCormick Journal: Langenbecks Arch Surg Date: 2020-06-12 Impact factor: 3.445
Authors: Kipp W Johnson; Khader Shameer; Benjamin S Glicksberg; Ben Readhead; Partho P Sengupta; Johan L M Björkegren; Jason C Kovacic; Joel T Dudley Journal: JACC Basic Transl Sci Date: 2017-06-26
Authors: Beth A Glenn; Ann S Hamilton; Narissa J Nonzee; Annette E Maxwell; Catherine M Crespi; A Blythe Ryerson; L Cindy Chang; Dennis Deapen; Roshan Bastani Journal: J Psychosoc Oncol Date: 2018-05-15